Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2017-02-02
2017-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extra-Corporeal Shock Wave Lithotripsy for Renal and Upper Ureteral Stones in Adults Under Locally Infiltrate d Anaesthetics ; a Clinical Randomized Controlled Study
NCT06462573
Extracorporeal Shockwave Lithotripsy, Electroconductive and Electrohydraulic Types
NCT06144372
Strategies to Maximise Patient Comfort During ESWL
NCT03379922
Retrolaminar Block Analgesia and Patient Comfort During Prone ESWL
NCT07177625
ESWL vs URS in Management of Upper Third Ureteric Calculi
NCT03559738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the end of the treatment patients are asked to fill in a questionnaire. They are asked if they were pleased to have had the opportunity to listen to music during ESWL, if they would like to listen to music again in case of further treatments, if they consider music helpful in relieving pain and discomfort during ESWL. Patients are also asked to mark their level of pain during each part of the treatment on a visual analogue scale (VAS) for pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Music during the first part of ESWL
Patients listen to music during the first part of ESWL treatment (first 1800 SW).
Music during the first part of ESWL
Music listening during first part of ESWL
Music during the second part of ESWL
Patients listen to music during the second part of ESWL treatment.
Music during the second part of ESWL
Music listening during second part of ESWL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Music during the first part of ESWL
Music listening during first part of ESWL
Music during the second part of ESWL
Music listening during second part of ESWL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No interest in music listening
* \< 18 years and \> 80 years
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A.O.U. Città della Salute e della Scienza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Bosio
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea MD Bosio, MD
Role: STUDY_CHAIR
AOU città dellaSalute e della Scienza, Torino
Andrea MD Bosio, MD
Role: PRINCIPAL_INVESTIGATOR
AOU città dellaSalute e della Scienza, Torino
Andrea MD Bosio, MD
Role: STUDY_DIRECTOR
AOU città dellaSalute e della Scienza, Torino
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Città della Salute e della Scienza
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOUCSSTURAB001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.